Official source Data mirrored from Centers for Medicare & Medicaid Services Open Payments · General Payments · as published 2026-06-30 View official record Methodology

Covered recipient · General Payments record

SHERMA PETER

Allopathic & Osteopathic Physicians Family Medicine

NPI
1518127687
CMS profile
22636
Location
SYLVANIA, GA

General Payments · PY2019–2025

$6,880.28

  • Reported across 316 records
  • CMS publication 2026-06-30

Latest program year · PY2025

$919.08

36 records · 0 disputed

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How these totals are calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

PY2025 · sorted by reported total

Nature of paymentAmountRecords
Food and Beverage $919.08 36

By paying entity

PY2025 · sorted by reported total

Paying entityAmountRecords
Acerta Pharma LLC $277.81 7
Amgen Inc. $209.20 12
Phathom Pharmaceuticals, Inc. $135.00 1
Lundbeck LLC $66.67 3
Novo Nordisk AS $53.62 3
ABBVIE INC. $46.46 3
Seqirus USA Inc $22.25 1
Lilly USA, LLC $20.18 1
ITI, Inc. $19.26 1
DEXCOM, INC. $18.68 1
Exact Sciences Corporation $18.17 1
GlaxoSmithKline, LLC. $16.20 1
Xeris Pharmaceuticals, Inc. $15.58 1

By program year

All program years on this page · sorted by year

Program yearAmountRecords
PY2019 $651.19 38
PY2020 $479.11 25
PY2021 $819.04 41
PY2022 $1,396.93 69
PY2023 $1,613.79 54
PY2024 $1,001.14 53
PY2025 $919.08 36

Payment records · PY2025 (36)

Sorted by paying entity, then date · as published by CMS

Program year 2025 201920202021202220232024 Record-level detail is published for PY2025; earlier years are summarised in “By program year”.
Paying entity Amount Date Nature of payment Dispute status Published Record ID Source
ABBVIE INC. $14.88 02/18/2025 Food and Beverage Undisputed 06/30/2026 1203590634 CMS
ABBVIE INC. $13.50 04/21/2025 Food and Beverage Undisputed 06/30/2026 1203590640 CMS
ABBVIE INC. $18.08 06/12/2025 Food and Beverage Undisputed 06/30/2026 1203590647 CMS
Amgen Inc. $20.66 01/07/2025 Food and Beverage Undisputed 06/30/2026 1228402952 CMS
Amgen Inc. $23.46 01/29/2025 Food and Beverage Undisputed 06/30/2026 1228402958 CMS
Amgen Inc. $22.53 02/20/2025 Food and Beverage Undisputed 06/30/2026 1228402964 CMS
Amgen Inc. $23.97 02/26/2025 Food and Beverage Undisputed 06/30/2026 1228402960 CMS
Amgen Inc. $21.33 04/30/2025 Food and Beverage Undisputed 06/30/2026 1228402948 CMS
Amgen Inc. $17.63 06/12/2025 Food and Beverage Undisputed 06/30/2026 1228402962 CMS
Amgen Inc. $17.26 07/08/2025 Food and Beverage Undisputed 06/30/2026 1228402956 CMS
Amgen Inc. $5.08 07/23/2025 Food and Beverage Undisputed 06/30/2026 1227154217 CMS
Amgen Inc. $16.85 08/11/2025 Food and Beverage Undisputed 06/30/2026 1228402950 CMS
Amgen Inc. $18.32 09/04/2025 Food and Beverage Undisputed 06/30/2026 1228402954 CMS
Amgen Inc. $4.13 10/01/2025 Food and Beverage Undisputed 06/30/2026 1227154215 CMS
Amgen Inc. $17.98 12/02/2025 Food and Beverage Undisputed 06/30/2026 1228402946 CMS
AstraZeneca Pharmaceuticals LP $18.09 02/17/2025 Food and Beverage Undisputed 06/30/2026 1206577850 CMS
AstraZeneca Pharmaceuticals LP $62.76 02/19/2025 Food and Beverage Undisputed 06/30/2026 1206181833 CMS
AstraZeneca Pharmaceuticals LP $125.00 04/24/2025 Food and Beverage Undisputed 06/30/2026 1206647949 CMS
AstraZeneca Pharmaceuticals LP $15.54 07/16/2025 Food and Beverage Undisputed 06/30/2026 1206408413 CMS
AstraZeneca Pharmaceuticals LP $19.13 09/16/2025 Food and Beverage Undisputed 06/30/2026 1206371733 CMS
AstraZeneca Pharmaceuticals LP $17.77 10/22/2025 Food and Beverage Undisputed 06/30/2026 1207023654 CMS
AstraZeneca Pharmaceuticals LP $19.52 11/11/2025 Food and Beverage Undisputed 06/30/2026 1206294764 CMS
Dexcom, Inc. $18.68 04/23/2025 Food and Beverage Undisputed 06/30/2026 1250525735 CMS
Exact Sciences Corporation $18.17 12/18/2025 Food and Beverage Undisputed 06/30/2026 1235291836 CMS
GlaxoSmithKline, LLC. $16.20 11/20/2025 Food and Beverage Undisputed 06/30/2026 1191561149 CMS
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) $19.26 10/30/2025 Food and Beverage Undisputed 06/30/2026 1241380502 CMS
Lilly USA, LLC $20.18 04/14/2025 Food and Beverage Undisputed 06/30/2026 1186909106 CMS
Lundbeck LLC $14.61 09/08/2025 Food and Beverage Undisputed 06/30/2026 1251834925 CMS
Lundbeck LLC $28.09 09/17/2025 Food and Beverage Undisputed 06/30/2026 1251834927 CMS
Lundbeck LLC $23.97 10/28/2025 Food and Beverage Undisputed 06/30/2026 1251834929 CMS
Novo Nordisk Inc $15.96 04/04/2025 Food and Beverage Undisputed 06/30/2026 1188231492 CMS
Novo Nordisk Inc $20.30 05/08/2025 Food and Beverage Undisputed 06/30/2026 1188176362 CMS
Novo Nordisk Inc $17.36 10/09/2025 Food and Beverage Undisputed 06/30/2026 1188531788 CMS
Phathom Pharmaceuticals, Inc. $135.00 08/20/2025 Food and Beverage Undisputed 06/30/2026 1219243506 CMS
Seqirus USA Inc $22.25 08/19/2025 Food and Beverage Undisputed 06/30/2026 1201093914 CMS
Xeris Pharmaceuticals, Inc. $15.58 06/13/2025 Food and Beverage Undisputed 06/30/2026 1250176406 CMS

Source & provenance

Dataset
CMS Open Payments — General Payments
Publisher of source data
Centers for Medicare & Medicaid Services
CMS publication date
2026-06-30
Program years on this page
2019, 2020, 2021, 2022, 2023, 2024, 2025
Source files
Dataset page · Bulk file · PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024 , PY2025
Generated from
OP_DTL_GNRL_PGYR2025_P06302026_06032026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.